The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.
Total Entries: 1251
| Date | Presenter | Affiliation | Title |
|---|---|---|---|
| October 5, 2021 | Nelly Friedrichsen, PhD | WashU Medicine | Spontaneous and treatment-induced amyloid-related imaging abnormality in dominantly inherited Alzheimer disease |
| September 28, 2021 | Jonathan Kipnis, PhD | WashU Medicine | New players in AD physiology |
| September 21, 2021 | Brian Carpenter, PhD | WashU Medicine | Beyond COVID: The Impact of the Pandemic on Older Adults in the St. Louis Region |
| September 14, 2021 | Eric Lenze, MD | WashU Medicine | Do mindfulness training and exercise improve cognitive functioning in older adults? Results from the MEDEX study |
| September 7, 2021 | Chihiro Sato, PhD | WashU Medicine | Tau biomarkers and kinetics in AD and non-AD tauopathies |
| August 31, 2021 | Denise Head, PhD | WashU Medicine | Spatial navigation in aging and Alzheimer disease |
| August 24, 2021 | Jessica Mozersky, PhD | WashU Medicine | Ethics of Disclosing Research Results in AD Dementia Research |
| August 17, 2021 | Andy Aschenbrenner, PhD | WashU Medicine | Cognitive Dynamics in Preclinical Alzheimer Disease: A story of attention, motivation, personality…and pathology? |
| August 10, 2021 | Cyrus Raji, MD, PhD | WashU Medicine | Contribution of Obesity in Conceptualizing Alzheimer Dementia Prevention |
| August 3, 2021 | Eric McDade, DO | WashU Medicine | A trial of gantenerumab or solanezumab indominantly inherited Alzheimer’s disease- The DIAN-TU-001 Trial Results |
| July 27, 2021 | No Seminar | AAIC Conference | |
| July 20, 2021 | No Seminar | Pre-AAIC Poster Session | |
| July 13, 2021 | Erik Musiek, MD, PhD & B. Joy Snider, MD, PhD | WashU Medicine | Aducanamab – what we know so far |
| July 6, 2021 | Chengran Yang, PhD | WashU Medicine | Identifying the protein quantitative trait loci (pQTLs) from participants with and without an Alzheimer Disease (AD) diagnosis |
| June 29, 2021 | John C. Morris, MD | WashU Medicine | State of the Knight ADRC |
| June 22, 2021 | Matt Gable, PhD | WashU | Recruitment and retention in longitudinal Alzheimer disease studies: Insights from a survey of ADRC study participants |
| June 15, 2021 | Logan Brase | WashU Medicine | Single-nucleus RNA sequencing identifies altered cell-specific expression profiles driven by Alzheimer Disease genetic variants |
| June 8, 2021 | Robert Fucetola, PhD | WashU Medicine | Indications for Neuropsychological Testing in the Dementia Evaluation |
| June 1, 2021 | Joyce (Joy) Balls-Berry, PhD, MPE | WashU Medicine | Understanding the Construct of Race in the Context of Racial Differences and Disparities in ADRD Research |
| May 25, 2021 | Suzanne Schindler, MD | WashU Medicine | New data on blood-based and CSF biomarkers in the Knight ADRC cohort |
| May 18, 2021 | Gregory VanSternen, MD | WashU Medicine | Retinal Imaging and Alzheimer’s Disease |
| May 11, 2021 | No Seminar | Annual Hope Center Retreat | |
| May 4, 2021 | Lauren Koenig | WashU Medicine | Impact of Race and AD in an Acute Stroke Cohort |
| April 27, 2021 | Joy Snider, MD | WashU Medicine | Clinical Trials Update 2021 – Knight ADRC Clinical Trials Unit |
| April 20, 2021 | Karin Meeker, PhD | WashU Medicine | Cognitive Intraindividual Variability, Phosphorylated Tau Sites, and Functional Brain Organization in AD |